Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 16NETWORK 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Recurrence 1Head and Neck Neoplasms 1Glioblastoma 1

Interventions

Radiotherapy 302Cisplatin 266Cyclophosphamide 230Doxorubicin 177Paclitaxel 170Vincristine 162Carboplatin 152Filgrastim 140Etoposide 139Gemcitabine 118Docetaxel 114Fluorouracil 113Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 92Leucovorin 90Gene Expression Profiling 82Granulocyte Colony-Stimulating Factor 75Specimen Handling 70Magnetic Resonance Spectroscopy 63Irinotecan 59Capecitabine 59Radiation 54Polymerase Chain Reaction 51Ifosfamide 51Rituximab 49Immunohistochemistry 49Daunorubicin 49Oxaliplatin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Re-Irradiation × Clear all
NCT05904119 2026-02-17

LEGATO

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
411 enrolled
CNS

Glioblastoma

NCT03981068 2020-09-25

DAHANCA 37. Re-irradiation With Proton Radiotherapy

Danish Head and Neck Cancer Group

Phase NA Unknown
20 enrolled
Head & Neck

Head and Neck Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡